Article
26 Dec 2025
Taking The LEAD: CMS Unveils The New LEAD Model, Focused On Long-Term Primary Care Success
AUTHORS CONTENT
Article
19 Jun 2025
New Tennessee Law Eases Physician Employment Restrictions For Certain Hospitals
Article
16 May 2025
Indiana Enacts Legislation Affecting Health Care Transactions And Imposing Ownership Reporting Requirements
Article
16 May 2025
CMMI Announces New Strategy
Article
19 Mar 2025
CMS Terminates Four Value-Based Care Models Early And Signals New Strategy
Article
07 Feb 2025
The Future Of Telemedicine Prescribing Comes Into Focus: New Final And Proposed Rules
Article
16 Jan 2025
Massachusetts HB5159 Expands Oversight Of Private Equity Investment In The Health Care Industry
Article
12 Dec 2024
CMS Finalizes Virtual Direct Supervision Extension And Rule Changes
Article
03 Dec 2024
New CMS Policies Position The MSSP For Expansion And Increased Savings
Article
20 Nov 2024
CMS Bolsters Primary Care With Advanced Primary Care Management Coverage
Article
28 Oct 2024
How To Comply With Stage One Of The Laboratory Developed Tests Final Rule
Article
17 Oct 2024
New Rule Curbs Impact Of Suspect DME Claims On 2023 MSSP Financial Calculations
Article
20 Sep 2024
More Losses Than Gains? OIG Declines To Approve Certain Medicare Advantage Gainsharing Arrangements In Advisory Opinion 24-08
Article
02 Sep 2024
CMS Finalizes New Mandatory Value-Based Payment Initiative: The Transforming Episode Accountability Model
Article
28 Jun 2024
Danielle Sloane And Morgan Tandy Examine Recent Court Cases Regarding Labs
Article
13 May 2024
The End Of An Era? FDA Finalizes LDT Rule But Grandfathers Many Existing LDTs
Article
09 May 2024
Danielle Sloane And Morgan Tandy Outline Recent Enforcement Actions And Court Cases Involving Labs
Article
30 Apr 2024
CMS Proposes New Mandatory Value-Based Payment Initiative: The Transforming Episode Accountability Model
Article
10 Oct 2023
Labs Take Note: New OIG Opinion Highlights That Fair Market Value Per Test Payments Can Still Violate The Anti-Kickback Statute
Article
09 Oct 2023
Extension Extended: DEA Continues Telemedicine Prescription Flexibilities Through 2024